BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.06%
This Quarter Est. Return
1 Year Est. Return
+15.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.84B
AUM Growth
+$450M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
28
New
Increased
Reduced
Closed

Top Buys

1 +$55.2M
2 +$41.9M
3 +$31.9M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$23.2M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$22.1M

Top Sells

1 +$25.8M
2 +$23.3M
3 +$22.7M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$21.3M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$9.92M

Sector Composition

1 Healthcare 86.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
26
-302,993
27
-1,014,800
28
-280,000